[Treatment of uremic patients with high bleeding risk].
Ogata
Hiroaki
H
Department of Internal Medicine, Showa University Northern Yokohama Hospital.
Kinugasa
Eriko
E
D000925:Anticoagulants / Q000008:administration & dosage; D001550:Benzamidines; D001791:Blood Platelet Disorders / Q000150:complications; D006146:Guanidines / Q000008:administration & dosage; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D006435:Renal Dialysis / Q000379:methods; D014511:Uremia / Q000150:complications* / Q000628:therapy*
D000925:Anticoagulants; D001550:Benzamidines; D006146:Guanidines; D006495:Heparin, Low-Molecular-Weight; C032855:nafamostat